Shellie Galley, OTR in De Soto, KS - Occupational Therapist

Shellie Galley, OTR is a Occupational Therapist based in De Soto, Kansas. Shellie Galley is licensed to practice in Kansas (license number 17-00589) and her current practice location is 33600 W 85th St, De Soto, Kansas. She can be reached at her office (for appointments etc.) via phone at (913) 585-1602.

NPI number for Shellie Galley is 1558472522 and her current mailing address is Po Box 831, Madill, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1558472522.

Contact Information

	Shellie Galley, OTR
	33600 W 85th St, De Soto, KS 66018-8118
	(913) 585-1602
	(913) 317-8288

Healthcare Provider's Profile

Full Name	Shellie Galley
Gender	Female
Speciality	Occupational Therapist
Location	33600 W 85th St, De Soto, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1558472522
Provider Enumeration Date: 08/31/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Shellie Galley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558472522	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	17-00589 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shellie Galley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shellie Galley, OTR Po Box 831, Madill, OK 73446-0831 Ph: (580) 795-3301	Shellie Galley, OTR 33600 W 85th St, De Soto, KS 66018-8118 Ph: (913) 585-1602

News Archive

NHS Tayside and Inhealthcare launch new app to support IBS patients

People suffering from irritable bowel syndrome are set to benefit from a new app launched by NHS Tayside, in partnership with Inhealthcare.

Study: Clinical criteria for mild cognitive impairment is better at predicting Alzheimer's disease

A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test.

Curemark awarded QTDP grant to advance development of CM-AT for autism

Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.

Blog examines RTS,S malaria vaccine trial results

In a post in the Center for Global Development's (CGD) "Global Health Policy" blog, Owen Barder, a senior fellow and director for Europe at the CGD, reports on the results of a large Phase III clinical trial conducted in Africa on the malaria vaccine candidate RTS,S, published online in the New England Journal of Medicine on Friday.

First standardized Russian-language test developed for aphasia-related disorders

Researchers from the HSE University Centre for Language and Brain have created and standardized a new test battery for diagnosing language disorders in people with brain damage.

Shellie Galley, OTR - Occupational Therapist in De Soto, KS